Chemical Nameflorbetapir F 18
Dosage FormInjection (intravenous; 500-1900 MBq/mL)
Drug ClassRadioactive diagnostic agents
CompanyEli Lilly and Company
Approval Year2012


  • Indicated for Positron Emission Tomography (PET) imaging of the brain to estimate β-amyloid neuritic plaque density in adult patients with cognitive impairment who are being evaluated for Alzheimer’s Disease (AD) and other causes of cognitive decline.
Last updated on 5/10/2021

More on this drug: Clinical Trials

Have we missed a study, or would you like to comment on a study?

Document TitleYearSource
Amyvid (florbetapir F 18) Prescribing Information2012Lilly USA, Indianapolis, IN